|
2022 Conference Publication Building a case for pancreas and liver targeted intereukin-22 therapy in fatty liver diseaseSajiir, Haressh, Wong, Kuan Yau, Mueller, Alexandra, Keshvari, Sahar, Wang, Ran, Wiid, Percival, Ramm, Grant, Macdonald, Graeme, Prins, John, McGuckin, Michael and Hasnain, Sumaira (2022). Building a case for pancreas and liver targeted intereukin-22 therapy in fatty liver disease. The International Liver Congress 2022, London, United Kingdom, 22-26 June 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0168-8278(22)00756-5 |
|
2018 Conference Publication Inflammatory Pathways in Adipocytes Are Activated By Ferritin and IronJaskowski, Lesley, Bridle, Kim, Britton, Laurence J., Jayachandran, Apama, Ramm, Grant A. and Crawford, Darrell H. G. (2018). Inflammatory Pathways in Adipocytes Are Activated By Ferritin and Iron. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San Francisco, CA, United States, 9-13 November 2018. Hoboken, NJ United States: Wiley. |
|
2016 Conference Publication Taurocholate induces proliferation and biliary differentiation of progenitor cells and stellate cell chemotaxis: insights into the pathophysiology of CF liver diseasePearen, M. A., Pozniak, K. N., Pereira, T. N., Kramer, C. S. M., Kalita-De Croft, P., Tirnitz-Parker, J. E. E., Olynyk, J. K., Shepherd, R. W., Lewindon, P. J. and Ramm, G. A. (2016). Taurocholate induces proliferation and biliary differentiation of progenitor cells and stellate cell chemotaxis: insights into the pathophysiology of CF liver disease. Gastroenterological Society of Australia, Australian Gastroenterology Week 2016, Adelaide, South Australia, 10–12 October 2016. HOBOKEN: Wiley. doi: 10.1111/jgh.13514 |
|
2013 Conference Publication The Developmental Origins of Biliary AtresiaKellermayer, Richard, Nagy-Szakal, Dorottya, Harris, Ronald A., Perreira, Tamara N., Lewindon, Peter J., Ramm, Grant A. and Shepherd, Ross (2013). The Developmental Origins of Biliary Atresia. 64th Annual Meeting and Postgraduate Course of the American Association for the Study of Liver Diseases, Washington Dc, 01 - 05 November, 2013. Hoboken, NJ United States: John Wiley and Sons, Inc.. doi: 10.1002/hep.26862 |
|
2011 Conference Publication Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver diseasePereira, T. N., Lewindon, P. J., Greer, R. M., Shepherd, R. W. and Ramm, G. A. (2011). Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease. Australian Gastroenterology Week (AGW, 2010), South Bank, QLD, Australia, 12-15 September 2011. MALDEN: WILEY-BLACKWELL. doi: 10.1111/j.1440-1746.2011.06819.x |
|
2010 Conference Publication The potential role of hepatic stellate cells in iron homeostasisRuddell, R. G., Darshan, D., Hoang-Le, D., Anderson, G. J. and Ramm, G. A. (2010). The potential role of hepatic stellate cells in iron homeostasis. AGW2010: Australian Gastroenterology Week 2010, Gold Coast, QLD, Australia, 20-23 October 2010. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2010.06450.x |
|
2010 Conference Publication Clinical expression of HFE-associated haemochromatosis in subjects under 40 years of ageDixon, J. L., Watt, E. E., Ramm, G. A., Subrmaniam, V. N., Powell, L. W. and Anderson, G. J. (2010). Clinical expression of HFE-associated haemochromatosis in subjects under 40 years of age. Australian Gastroenterology Week 2010, Gold Coast , QLD Australia, 20-23 October 2010. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2010.06451.x |
|
2010 Conference Publication Diabetes is associated with fibrosis progression in haemochromatosisWood, M. J., Vigh, S., Dixon, J. L., Ramm, G. A. and Powell, L. W. (2010). Diabetes is associated with fibrosis progression in haemochromatosis. Australian Gastroenterology Week 2010, Gold Coast, Qld, Australia, 20-23 October 2010. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2010.06457.x |
|
2010 Conference Publication Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasisBurke, M. L., McManus, D. P., Ramm, G. A., Duke, M., Li, Y., Jones, M. K. and Gobert, G. N. (2010). Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis. Australian Gastroenterology Week (AGW) 2010, Gold Coast, QLD, Australia, 20-23 October 2010. Carlton South, VIC, Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2010.06450.x |
|
2010 Conference Publication The role of the ductular reaction in the progression of hepatic fibrosis in haemochromatosisWood, MJ, Powell, LW, Ramm, GA and Clouston, AD (2010). The role of the ductular reaction in the progression of hepatic fibrosis in haemochromatosis. Australian Gastroenterology Week 2010, Gold Coast , QLD, Australia, 20-23 October 2010. Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2010.06457.x |
|
2010 Conference Publication Cells of the ductular reaction produce the chemokine monocyte chemotaxis protein-1, which initiates fibrosis in pediatric cholestatic liver diseasePereria, T.N., Lewindon, P.J., Shepherd, R.W., Walsh, M.J., Tirnitz-Parker, J., Olynyk, J.K., Yeoh, G. and Ramm, G.A. (2010). Cells of the ductular reaction produce the chemokine monocyte chemotaxis protein-1, which initiates fibrosis in pediatric cholestatic liver disease. Australian Gastroenterology Week 2010, Gold Coast, Queensland, Australia, 20 - 23 October 2010. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2010.06450.x |
|
2009 Conference Publication DETECTION AND FOLLOW-UP OF LIVER FIBROSIS IN CYSTIC FIBROSIS: A ROLE FOR DIAGNOSTIC LIVER BIOPSY AND SERUM MARKERS IN THE EVALUATION OF AND FOLLOW UP OF CYSTIC FIBROSIS LIVER DISEASEWalsh, MJ, Lewindon, PJ, Shepherd, RW, Greer, RM, Bell, S and Ramm, GA (2009). DETECTION AND FOLLOW-UP OF LIVER FIBROSIS IN CYSTIC FIBROSIS: A ROLE FOR DIAGNOSTIC LIVER BIOPSY AND SERUM MARKERS IN THE EVALUATION OF AND FOLLOW UP OF CYSTIC FIBROSIS LIVER DISEASE. 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston MA, OCT 30-NOV 03, 2009. HOBOKEN: JOHN WILEY & SONS INC. |
|
2009 Conference Publication Detection and follow-up of hepatic fibrosis in cystic fibrosis: A role for diagnostic liver biopsy and serum markers in evaluating outcomes of cystic fibrosis liver diseaseWalsh, M. J., Lewindon, P. J., Shepherd, R. W., Greer, R. M., Williamson, R., Pereira, T. N., Frawley, K, Bell, S., Smith, J. L. and Ramm, G. A. (2009). Detection and follow-up of hepatic fibrosis in cystic fibrosis: A role for diagnostic liver biopsy and serum markers in evaluating outcomes of cystic fibrosis liver disease. Australia & New Zealand Medical & Surgical Gastrointestinal Week 2009, Sydney, NSW, Australia, 21 - 24 October 2009. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2009.06050.x |
|
2008 Conference Publication Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosisCrawford, Darrell H., Murphy, Therese L., Ramm, Louise E., Fletcher, Linda M., Clouston, Andrew D., Anderson, Gregory J., Subramaniam, V. Nathan, Powell, Lawrie W. and Ramm, Grant A. (2008). Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. The Liver Meeting 2008: 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA, U.S.A., 31 October-4 November 2008. Hoboken, NJ, U.S.A.: John Wiley & Sons. doi: 10.1002/hep.22641 |
|
2008 Conference Publication Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosisCrawford, D. H. G., Murphy, T. L., Ramm, L. E., Fletcher, L. M., Clouston, A. D., Anderson, G. J., Subramaniam, V. N., Powell, L. W. and Ramm, G. A. (2008). Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. AGW 2008: Australian Gastroenterology Week 08, Brisbane, QLD, Australia, 22-25 October 2008. MALDEN: WILEY-BLACKWELL PUBLISHING, INC. doi: 10.1111/j.1440-1746.2008.05613.x |
|
2005 Conference Publication Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver diseaseAnderson, Greg, Frazer, David M., Bridle, Kim R., Macdonald, Graeme A., Smith, Jeffrey L., Turlin, Bruno, Subramaniam, Nathan, Crawford, Darrell H., Powell, Lawrie W. and Ramm, Grant A. (2005). Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease. 47th Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, 10-13 December, 2005. Washington, D.C., USA: American Society of Hematology. |
|
2005 Conference Publication Role of serum markers in detection and monitoring progression of CF liver diseaseRamm, Grant A., Pereira, Tamara N. and Lewindon, Peter J. (2005). Role of serum markers in detection and monitoring progression of CF liver disease. The 19th Annual North American Cystic Fibrosis Conference, Baltimore, Maryland, U.S.A., 20-23 October 2005. New York, U.S.A.: Wiley. doi: 10.1002/ppul.20314 |
|
2004 Conference Publication Signals for hepatic figrogenesis in pediatric cholestatic liver disease: Review and hypothesisRamm, G. A., Hoskins, A. C., Greco, S. A., Pereira, T. N. and Lewindon, P. J. (2004). Signals for hepatic figrogenesis in pediatric cholestatic liver disease: Review and hypothesis. 11th International Symposium on the Cells of the Hepatic Sinusoid and their Relation to Other Cells, Tucson, Arizona, U.S.A., 25–29 August 2002. London, United Kingdom: BioMed Central. doi: 10.1186/1476-5926-2-S1-S5 |
|
2001 Conference Publication Hepatic expression of iron transporters in patients with hemochromatosis or hepatitis C virus infectionBrindle, K.R., Frazer, D.M., Crawford, D.H. and Ramm, G.A. (2001). Hepatic expression of iron transporters in patients with hemochromatosis or hepatitis C virus infection. 52th Annual Meeting of the American Association for the Study of Liver Diseases, Dallas, TX, United States, 9-13 November 2001. Hoboken, NJ, United States: John Wiley & Sons. |
|
2000 Conference Publication Cystic fibrosis liver disease and liver biopsy: improved accuracy of assessment with dual samplingLewindon, P. J., Walker, N. I., Williamson, R., Smith, J. L., Pereira, T. N., Shepherd, R. W. and Ramm, G. A. (2000). Cystic fibrosis liver disease and liver biopsy: improved accuracy of assessment with dual sampling. Australian Gastroenterology Week 2000, Hobart, 18-21 Oct, 2000. Asia: Blackwell Science. |
